Manufacturing facility
Natco Pharma USA LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 300 Interpace Pkwy Bldg C Ste 100, Parsippany, New Jersey (NJ) 07054, United States (USA)
- Operations here
- labelrepack
- FDA identifiers
- FEI 3012899356 · DUNS 079590418
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Megestrol AcetateNatco Pharma USA LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.